Greenberg A
Division of Nephrology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Am J Med Sci. 2000 Jan;319(1):10-24.
Diuretics are widely used and generally safe, but like any therapeutic agents, they may cause side effects.
A review of recent literature pertaining to diuretic usage was performed, with emphasis on specific reports of side effects. Reports of large-scale hypertension trials employing diuretics were also examined for descriptions of diuretic-related complications.
All diuretics promote excretion of sodium. Depending upon the site and mode of action, some diuretics increase excretion of potassium, chloride, calcium, bicarbonate, or magnesium. Some can reduce renal excretion of electrolyte-free water, calcium, potassium, or protons. Consequently, electrolyte and acid-base disorders commonly accompany diuretic use. Except for the mildly natriuretic collecting duct agents, which are used mainly to limit potassium excretion, all diuretics can cause volume depletion with prerenal azotemia. Loop agents and distal convoluted tubule agents, such as the thiazides, produce hypokalemic, hypochloremic, metabolic alkalosis that responds to potassium chloride replacement. Carbonic anhydrase inhibitors produce less hypokalemia and volume depletion but commonly induce metabolic acidosis that is often symptomatic. The potassium-sparing agents also limit proton excretion, and spironolactone may produce metabolic acidosis. Hyperkalemia is a leading complication of the potassium-sparing agents, especially in patients with an underlying tendency for hyperkalemia. Thiazide diuretics, in particular, have been linked to glucose intolerance, which may be an effect of hypokalemia rather than the diuretic itself. Whether diuretic-induced hypokalemia increases cardiovascular risk is controversial. Loop agents and thiazides may lead to hyponatremia, which, in the case of thiazides, may cause permanent neurologic damage. Dose-related reversible or irreversible ototoxicity may complicate treatment with loop agents. Nephrocalcinosis, nephrolithiasis, hypomagnesemia, and hyperuricemia can potentially complicate treatment with some diuretic agents. Reported idiosyncratic reactions to diuretics include interstitial nephritis, noncardiogenic pulmonary edema, pancreatitis, and myalgias.
Potential side effects of a diuretic can often be anticipated from its mode of action on the kidney. These complications may be mitigated with careful monitoring, dosage adjustment, and replacement of electrolyte losses. Other side effects are idiosyncratic and cannot be prevented.
利尿剂应用广泛且一般安全,但与任何治疗药物一样,它们可能会引起副作用。
对近期有关利尿剂使用的文献进行综述,重点关注副作用的具体报道。还查阅了使用利尿剂的大规模高血压试验报告,以了解利尿剂相关并发症的描述。
所有利尿剂均促进钠排泄。根据作用部位和作用方式,一些利尿剂会增加钾、氯、钙、碳酸氢盐或镁的排泄。一些利尿剂可减少无电解质水、钙、钾或质子的肾排泄。因此,利尿剂使用常伴有电解质和酸碱紊乱。除主要用于限制钾排泄的轻度利钠集合管制剂外,所有利尿剂均可导致容量耗竭伴肾前性氮质血症。袢利尿剂和远曲小管利尿剂(如噻嗪类)可导致低钾血症、低氯血症、代谢性碱中毒,补充氯化钾后可缓解。碳酸酐酶抑制剂引起的低钾血症和容量耗竭较少,但常诱发代谢性酸中毒,且常伴有症状。保钾利尿剂也会限制质子排泄,螺内酯可能会导致代谢性酸中毒。高钾血症是保钾利尿剂的主要并发症,尤其是在有高钾血症潜在倾向的患者中。特别是噻嗪类利尿剂与葡萄糖耐量异常有关,这可能是低钾血症的作用而非利尿剂本身的作用。利尿剂引起的低钾血症是否会增加心血管风险存在争议。袢利尿剂和噻嗪类利尿剂可能导致低钠血症,就噻嗪类而言,这可能会导致永久性神经损伤。剂量相关的可逆或不可逆耳毒性可能会使袢利尿剂治疗复杂化。肾钙质沉着、肾结石、低镁血症和高尿酸血症可能会使某些利尿剂治疗复杂化。报道的对利尿剂的特异反应包括间质性肾炎、非心源性肺水肿、胰腺炎和肌痛。
利尿剂的潜在副作用通常可根据其对肾脏的作用方式预测。通过仔细监测、调整剂量和补充电解质丢失,这些并发症可能会减轻。其他副作用是特异质性的,无法预防。